The North America Biosimilars Market was worth $1.26 billion in 2016 and estimated to be growing at a CAGR of 38%, to reach $6.31 billion by 2021. Biosimilars are emerging as one of the most important sector in the healthcare industry. With increasing healthcare costs, biosimilars are being looked upon as an affordable treatment option. Growing economies are observing comprehensive growth in biosimilars industry from demanding clinical needs of therapeutics. Rise in GDP and healthcare ... Read more
